Cardero Therapeutics' Unattributed - II Round

Cardero Therapeutics raised a round of funding on October 16, 2014.

Cardero Therapeutics is a Drug Discovery and Development company involved in various preclinical and clinical programs targeting metabolic disorders and cardiovascular diseases having a mitochondrial …

Articles about Cardero Therapeutics' Unattributed - II Round: